December 2025 in “International Journal of Cosmetic Science” A new tool helps better assess and treat hair loss in Chinese men.
November 2025 in “Caderno Pedagógico” In this study, the combination of castor or cedar oils with high-frequency treatment was associated with the growth of new hair, improved hair density, and increased hair strand thickness among patients with androgenetic alopecia, although it did not significantly affect scalp oiliness.
November 2025 in “Journal of Investigative Dermatology” Estetrol may help prevent hair loss and support hair growth in women.
November 2025 in “Revista Políticas Públicas & Cidades” In this case study, the combination of microneedling and intradermal therapy was observed to effectively stimulate hair growth and improve hair density in a menopausal woman with androgenetic alopecia, resulting in enhanced self-esteem and cosmetic satisfaction.
November 2025 in “Health Promotion Evidence” This study reviewed interventions for post-COVID-19 alopecia and concluded that integrated physiotherapeutic strategies, including photobiomodulation, micro-needling, electrotherapy, and scalp massage, can reduce hair loss and improve hair density, contributing positively to patient quality of life.
October 2025 in “Frontiers in Toxicology” This study found that a human relevant potency threshold for estrogen receptor alpha agonism may serve as a health-protective screening tool, and highlights inference performance as essential for scientific confidence frameworks.
October 2025 in “Minerva Obstetrics and Gynecology” This review suggests that estroprogestins with anti-androgenic progestins, like cyproterone acetate and drospirenone, may effectively manage androgen excess in PCOS women, considering individual patient profiles.
October 2025 in “Journal of the Endocrine Society” In this case report, a transgender woman with refractory epilepsy began estrogen therapy for gender-affirming purposes, experiencing stable epilepsy and reduced gender dysphoria through ongoing multidisciplinary care, highlighting the importance of careful management for similar patients.
October 2025 in “Journal of the Endocrine Society” The researchers reported that individuals with non-alcoholic fatty liver disease and nutritional deficiency often exhibit iron and estrogen deficiencies, which may contribute to liver cell stress and fibrosis.
This study successfully established a functionally stable immortalized sheep granulosa cell line (GCs-SV40T-GFP) that can passaged up to 50 generations, maintaining morphological stability and estradiol secretion, offering a valuable model for research into animal reproductive function and hormone regulation.
August 2025 in “DS Reviews of Research in Life Sciences” In this study, women with polycystic ovary syndrome showed significantly higher levels of DHEA, IL-6, and TNF-α compared to healthy controls, indicating a possible link between these biomarkers and PCOS.
This case report discusses a patient with female androgenetic alopecia and chronic telogen effluvium, emphasizing the importance of follicular unclogging to enhance treatment effectiveness, combining deep cleaning, caffeine application, physical stimulation, and lifestyle changes as an individualized, effective alternative to oral medications.
August 2025 in “Ciencia Latina Revista Científica Multidisciplinar” This study identified various therapeutic applications of rosemary in humans, including cellular, dental, dermatological, metabolic, respiratory, and nervous system conditions, supporting its potential in evidence-based medicine.
July 2025 in “Journal of Cosmetic Dermatology” This study established a model of heat-damaged hair to assess hair care products, finding that daily hair drying for a month causes notable cuticle lifting, reduced mechanical properties, and increased protein release, and the model simulates even more severe damage.
July 2025 in “Reproductive Biology and Endocrinology” This study found that early postnatal androgen activity affects the long-term expression of hormone receptors differently in female Wistar rats, influencing neural system programming during development.
July 2025 in “Humanitarian and Natural Sciences Journal” In this study, women with hair loss were found to have significantly lower levels of vitamin D and ferritin compared to healthy controls, suggesting that these micronutrients may play a role in hair health and could be important in nutritional assessments for hair loss conditions.
July 2025 in “The Egyptian Journal of Hospital Medicine” This study found that serum GPER-1 levels may serve as a biomarker for differentiating androgenetic alopecia from telogen effluvium and healthy controls, although its ability to distinguish between AGA and TE is limited.
June 2025 in “Universities Journal of Phytochemistry and Ayurvedic Heights” This study evaluated the wedelolactone content and antimicrobial activity of Eclipta alba and Wedelia chinensis extracts, finding a potential relationship between the concentration of wedelolactone and their in vitro antimicrobial effects against several pathogenic bacteria and yeast.
April 2025 in “Middle East Fertility Society Journal” This study established reference values for nine fertility hormones important in diagnosing and monitoring PCOS in Pakistani and other subcontinent populations.
March 2025 in “Yemeni Journal For Medical Sciences” This study found that 89.3% of female college students in Aden, Yemen, had hypovitaminosis D, with sunscreen use and lack of vitamin D supplements significantly associated with this condition.
In this study, rosemary extracts (essential oil, hydrolate, and alcoholic extract) significantly stimulated hair growth in male mice compared to distilled water and even to commercial minoxidil, with rosemary groups showing statistically superior results on hair length.
January 2025 in “Dialnet (Universidad de la Rioja)” In this multicenter study, adipose-derived stem cell-enriched fat grafting achieved higher satisfaction and better clinical outcomes compared to platelet-rich plasma and hyaluronic acid filler in aesthetic interventions.
November 2024 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” In this study, researchers investigated the use of the Pulse Booster Drug Delivery Mesojectgun technology for non-invasive treatment of scalp conditions, finding improvements in hair volume, thickness, and reduction of hair loss in four participants with alopecia after applying specific active ingredients.
October 2024 in “Journal of Cutaneous and Aesthetic Surgery” The authors suggest that during hair transplantation for hair loss, the parietal eminence area should be prioritized along with the mid-scalp to address future noticeable thinning, especially since this area often becomes more conspicuous over time.
October 2024 in “Revista Científica Dynamikos” This study describes the establishment of a hair clinic in Bogotá aimed at providing affordable hair restoration treatments for middle-income individuals, focusing on market, technical, administrative, and financial analyses to ensure business viability.
October 2024 in “Journal of the Endocrine Society” In this retrospective chart review, researchers observed that estrogen monotherapy effectively suppressed testosterone levels below 50ng/dL in all transfeminine patients studied, particularly those using injectable formulations, though the small sample size and ongoing data collection limit these findings.
October 2024 in “Journal of the Endocrine Society” In this retrospective study, among transfeminine patients aged 19-81 receiving gender-affirming estrogen therapy, 100% achieved testosterone suppression without anti-androgens when serum estradiol exceeded 100pg/mL, predominantly using injectable estrogen.
September 2024 in “Journal of the American Academy of Dermatology” This study found that estetrol (E4) significantly prolonged the anagen phase and increased hair matrix keratinocyte proliferation in cultured human hair follicles, suggesting its potential as a treatment for female pattern hair loss.
August 2024 in “Research Square (Research Square)” This study found that women taking 5α-reductase inhibitors (5aRI) for alopecia had a lower risk of breast cancer compared to those not using these medications, with no increased risk of developing ovarian or endometrial cancer.
February 2024 in “Hormones” This study surveyed individuals seeking estrogen-based gender-affirming hormone therapy, revealing that improving life satisfaction and femininity are top treatment goals, and highlighting the need for trials aligned with community priorities.